ArticleJournal of investigative medicine high impact case reports

Clinical Response to Osimertinib in a Non-Small-Cell Lung Cancer Patient With EGFR L833V/H835L Mutations: A Case Report.

Jowan Al-Nusair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.